Novo Nordisk
NVO
#27
Rank
โ‚น30.998 T
Marketcap
โ‚น6,892
Share price
-9.43%
Change (1 day)
-36.54%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.592 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น41.89 Billion. , an increase over its 2023 earnings that were of โ‚น1.347 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น1.653 T22.75%
2023 โ‚น1.347 T57.64%
2022 โ‚น854.50 B5.35%
2021 โ‚น811.10 B12.47%
2020 โ‚น721.17 B13.07%
2019 โ‚น637.81 B-3.35%
2018 โ‚น659.92 B1.79%
2017 โ‚น648.29 B4.52%
2016 โ‚น620.25 B9.42%
2015 โ‚น566.87 B8.24%
2014 โ‚น523.72 B3.45%
2013 โ‚น506.26 B19.02%
2012 โ‚น425.37 B15.21%
2011 โ‚น369.23 B17.71%
2010 โ‚น313.66 B24.78%
2009 โ‚น251.37 B10.62%
2008 โ‚น227.22 B55.97%
2007 โ‚น145.68 B7.07%
2006 โ‚น136.07 B18.18%
2005 โ‚น115.14 B11.33%
2004 โ‚น103.42 B
2002 โ‚น66.54 B-14.39%
2001 โ‚น77.72 B-52.82%
2000 โ‚น164.73 B250%
1999 โ‚น47.06 B31.21%
1998 โ‚น35.87 B34.31%
1997 โ‚น26.70 B11.46%
1996 โ‚น23.96 B9.03%
1995 โ‚น21.97 B-3.15%
1994 โ‚น22.69 B-0.67%
1993 โ‚น22.84 B45.38%
1992 โ‚น15.71 B-13.81%
1991 โ‚น18.22 B37.12%
1990 โ‚น13.29 B-0.79%
1989 โ‚น13.40 B26.2%
1988 โ‚น10.61 B24.97%
1987 โ‚น8.49 B-0.9%
1986 โ‚น8.57 B-7.78%
1985 โ‚น9.29 B24.87%
1984 โ‚น7.44 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น606.13 B-63.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.107 T-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น731.5 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น693.34 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France